查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855811

2025年全球癌細胞分析市場報告

Cancer Cell Analysis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，癌細胞分析市場呈現強勁成長勢頭，預計將從2024年的104.4億美元成長到2025年的114.1億美元，複合年成長率達9.3%。這一成長主要受以下因素驅動：癌症發病率上升、政府加大對癌症研究的津貼、研究機構與生物技術公司合作加強、對液態切片和其他非侵入性檢測方法的需求不斷成長，以及對個性化癌症治療的需求日益成長。

預計未來幾年，癌細胞分析市場將維持強勁成長，2029年市場規模將達到160.9億美元，複合年成長率（CAGR）為9.0%。預測期內的成長預計將受到以下因素的驅動：對高通量分析技術的需求不斷成長、對早期檢測和篩檢的重視、對單細胞和稀有細胞研究的日益關注、對精準臨床決策支援的需求不斷成長，以及數位病理平台的廣泛應用。預測期內的主要趨勢包括：人工智慧在癌細胞成像和分析中的應用、次世代定序平台的進步、多重生物標記檢測方法的應用、免疫腫瘤學研究工具的進步，以及生物資訊學和巨量資料分析在實現個人化治療方面的日益普及。

癌細胞分析是利用實驗室和成像技術對癌細胞進行全面研究，以了解其結構、行為和基因特徵。其主要目標是幫助癌症患者早期發現、準確診斷並制定個人化治療方案。此外，它還有助於研究腫瘤進展、評估治療效果、識別生物標記以及開發新的治療方法，從而推進精準腫瘤學的發展並改善患者預後。

癌細胞分析市場的主要產品和服務包括試劑和耗材、儀器、配件、軟體和服務。試劑和耗材包含用於準確檢測和分析癌細胞的化學物質和生物材料。分析類型包括基因組學、蛋白質組學、代謝體學、轉錄組學和組織病理學。關鍵技術包括次世代定序儀(NGS)、聚合酵素鏈鎖反應(PCR)、質譜分析、流式細胞技術和免疫組織化學 (IHC)。應用領域涵蓋生物標記發現、藥物研發、精準醫療、臨床診斷和研究活動。最終用戶包括製藥和生物技術公司、醫院和臨床實驗室以及學術和研究機構。

美國關稅的迅速上漲以及由此引發的貿易摩擦（始於2025年春季）對醫療設備行業產生了重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所抵制價格上漲，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供癌細胞分析市場統計數據，例如全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商機，以及您在癌細胞分析行業取得成功所需的各種數據。本癌細胞分析市場研究報告全面概​​述了您所需的一切資訊，並對行業現狀和未來發展趨勢進行了詳細分析。

預計未來幾年，癌症研究投入的不斷增加將推動癌細胞分析市場的成長。隨著全球癌症負擔持續加重，各國政府和私人機構正增加對癌症研究的投入，旨在改善診斷方法並開發有效的治療方法。癌細胞分析對癌症研究至關重要，因為它能夠提供腫瘤生物學、異質性和進展的詳細資訊，使研究人員能夠識別新的生物標記、評估治療反應並設計標靶治療。例如，美國國家癌症研究所（NCI）報告稱，其2024會計年度的癌症研究預算為72億美元，比上年度成長1.7%。這很可能導致癌症研究投入的增加，並推高對癌細胞分析技術的需求。

癌症細胞分析市場的主要企業正致力於稀有細胞和循環性腫瘤細胞(CTC) 富集等創新技術，以推進癌症研究和診斷能力。稀有細胞和 CTC 富集技術能夠從血液樣本中分離並捕獲極低頻率的癌細胞，從而提供有關腫瘤異質性、疾病進展和治療反應的關鍵資訊。例如，2024 年 6 月，總部位於美國的生命科學研究和臨床診斷公司 Bio-Rad Laboratories 推出了 Celselect Slides 2.0，這是一種先進的微流體晶片技術，旨在透過其 Genesis 細胞分離系統提高稀有細胞和 CTC 的捕獲效率。最新版本將微腔數量從 56,400 個增加到 140,800 個，使每個晶片的樣本容量提高了 2.5 倍。此外，它還能無縫整合到現有工作流程中，無需進行重大調整，從而促進癌症研究並提高細胞分析效率。

2022年2月，美國診斷和醫療保健公司LabCorp以5.75億美元收購了Personal Genome Diagnostics Inc.。此次收購旨在透過整合PGDx全面的液態切片和基於組織的癌細胞分析技術，增強LabCorp在腫瘤學和癌症基因組學領域的實力。總部位於美國的Personal Genome Diagnostics Inc.專注於癌細胞分析和基因組學，為精準腫瘤學和臨床決策支援提供先進的診斷解決方案。

研究市場包括提供諮詢和研究支援服務、數據分析和生物資訊服務、藥物篩檢和療效測試、組織病理學和數位病理學服務以及臨床試驗支援服務等服務的營業單位所獲得的收入。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。癌細胞分析市場還包括數位病理掃描儀、微流體裝置、液態切片套件和免疫組織化學 (IHC)套件的銷售。該市場的價值為“出廠價”，即商品製造商或創造者銷售的商​​品價值，無論銷售對像是其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球癌細胞分析：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球癌細胞分析市場：成長率分析
  • 全球癌細胞分析市場表現：規模與成長，2019-2024年
  • 全球癌細胞分析市場預測：規模與成長，2024-2029年，2034年預測
  • 全球癌細胞分析：潛在市場規模（TAM）

第6章 市場細分

  • 全球癌細胞分析市場依產品/服務、效能及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 試劑和耗材
  • 裝置
  • 配件
  • 軟體
  • 服務
  • 全球癌細胞分析市場按類型、表現和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 基因組分析
  • 蛋白質體學分析
  • 代謝組學分析
  • 轉錄組分析
  • 組織病理學分析
  • 全球癌細胞分析市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 次世代定序儀（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 質譜分析
  • 流式細胞技術
  • 免疫組織化學（IHC）
  • 全球癌細胞分析市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 生物標記發現
  • 藥物開發與發現
  • 精準醫療
  • 臨床診斷
  • 研究與開發
  • 全球癌細胞分析市場：依最終用途分類，實際結果與預測，2019-2024年、2024-2029年預測、2034年預測
  • 製藥和生物技術公司
  • 醫院和臨床實驗室
  • 學術研究機構
  • 其他最終用途
  • 全球癌細胞分析市場：按試劑和耗材、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 細胞培養基
  • 抗體
  • 染色和染料
  • 酵素試劑套件
  • 緩衝液和溶液
  • 全球癌細胞分析市場：依儀器、類型、表現和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 流式細胞儀
  • 顯微鏡
  • 細胞分析儀
  • 自動細胞計數器
  • 影像系統
  • 全球癌細胞分析市場：依配件、類型、實際結果及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 移液管和吸頭
  • 培養皿和培養瓶
  • 微孔盤
  • 過濾單元
  • 樣品管
  • 全球癌細胞分析市場：依軟體、類型、實際數據和預測數據細分，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 數據分析軟體
  • 影像分析軟體
  • 測試資訊管理系統
  • 視覺化工具
  • 量化軟體
  • 全球癌細胞分析市場：按服務、類型、表現和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 技術支援服務
  • 安裝和維護服務
  • 校對服務
  • 培訓和教育服務
  • 諮詢服務

第7章 區域和國家分析

  • 全球癌細胞分析市場：依地區分類，結果及預測，2019-2024年、2024-2029年預測、2034年預測
  • 全球癌細胞分析市場：按國家、績效和預測分類，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 癌細胞分析市場：競爭格局
  • 癌細胞分析市場：公司概況
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Merck KGaA
  • GE Healthcare Technologies Inc.
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • Olympus Corporation
  • Illumina Inc.
  • Sartorius AG
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Bruker Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Miltenyi Biotec BV & Co. KG
  • Abcam plc

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年癌細胞分析市場：提供新機會的國家
  • 2029年癌細胞分析市場：新興細分市場帶來新機會
  • 2029年癌細胞分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38460

Cancer cell analysis is the comprehensive examination of cancer cells using laboratory and imaging techniques to understand their structure, behavior, and genetic profile. Its primary purpose is to support early detection, accurate diagnosis, and personalized treatment strategies for cancer patients. It also enables the study of tumor progression, evaluation of treatment responses, identification of biomarkers, and development of new therapies, thereby advancing precision oncology and improving patient outcomes.

The primary products and services in the cancer cell analysis market include reagents and consumables, instruments, accessories, software, and services. Reagents and consumables consist of essential chemical and biological materials used to detect and analyze cancer cells with accuracy. The types of analysis include genomic, proteomic, metabolomic, transcriptomic, and histopathological studies. Key technologies involve next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, flow cytometry, and immunohistochemistry (IHC). Applications cover biomarker discovery, drug development, precision medicine, clinical diagnosis, and research activities. End-users include pharmaceutical and biotechnology companies, hospitals and clinical laboratories, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cancer cell analysis market research report is one of a series of new reports from The Business Research Company that provides cancer cell analysis market statistics, including cancer cell analysis industry global market size, regional shares, competitors with a cancer cell analysis market share, detailed cancer cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the cancer cell analysis industry. The cancer cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer cell analysis market size has grown strongly in recent years. It will grow from $10.44 billion in 2024 to $11.41 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. Growth in the historic period was driven by the rising prevalence of cancer, increased government funding for cancer research, stronger collaboration between research institutions and biotechnology companies, growing demand for liquid biopsy and other non-invasive testing methods, and the increasing need for personalized cancer therapies.

The cancer cell analysis market size is expected to see strong growth in the next few years. It will grow to $16.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. Growth in the forecast period is expected to be supported by rising demand for high-throughput analysis techniques, greater emphasis on early detection and screening, increasing focus on single-cell and rare cell studies, higher need for accurate clinical decision support, and wider adoption of digital pathology platforms. Key trends anticipated for the forecast period include the integration of AI in cancer cell imaging and analysis, advancements in next-generation sequencing platforms, adoption of multiplex biomarker detection assays, progress in immuno-oncology research tools, and greater use of bioinformatics and big data analytics to enable personalized therapy.

The increasing investments in cancer research are expected to propel the growth of the cancer cell analysis market in the coming years. As the global burden of cancer continues to rise, governments and private organizations are investing more funds into studies aimed at enhancing diagnostic methods and developing effective treatments. Cancer cell analysis is crucial to cancer research as it provides detailed insights into tumor biology, heterogeneity, and progression, allowing researchers to identify new biomarkers, evaluate treatment responses, and design targeted therapies. For example, the National Cancer Institute, a U.S.-based government agency, reported that the cancer research budget for the fiscal year 2024 was $7.2 billion, marking a 1.7% increase from the previous year. Therefore, the rising investments in cancer research will fuel the demand for cancer cell analysis technologies.

Key players in the cancer cell analysis market are focusing on innovations such as rare cell and circulating tumor cell (CTC) enrichment technologies to enhance cancer research and diagnostic capabilities. Rare cell and CTC enrichment involves isolating and capturing extremely low-frequency tumor cells from blood samples, which provide vital information about tumor heterogeneity, disease progression, and treatment responses. For example, in June 2024, Bio-Rad Laboratories Inc., a life science research and clinical diagnostics company based in the U.S., introduced Celselect Slides 2.0, an advanced microfluidic slide technology designed to improve rare cell and CTC capture with its Genesis Cell Isolation System. The updated version allows for 2.5 times more sample capacity per slide by increasing microchambers from 56,400 to 140,800. It also integrates seamlessly into existing workflows, boosting cancer research and enhancing the efficiency of cell analysis without requiring significant adjustments.

In February 2022, Labcorp, a U.S.-based diagnostics and healthcare company, acquired Personal Genome Diagnostics Inc. for $575 million. This acquisition is aimed at strengthening Labcorp's oncology and cancer genomics portfolio by incorporating PGDx's comprehensive liquid biopsy and tissue-based cancer cell analysis technologies. Personal Genome Diagnostics Inc., a U.S.-based company specializing in cancer cell analysis and genomics, offers advanced diagnostic solutions that support precision oncology and clinical decision-making.

Major players in the cancer cell analysis market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Olympus Corporation, Illumina Inc., Sartorius AG, PerkinElmer Inc., Sysmex Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Miltenyi Biotec B.V. & Co. KG, Abcam plc, Promega Corporation, Creative Bioarray Inc., NanoCellect Biomedical Inc., Cell Biolabs Inc., Meiji Techno Co. Ltd.

North America was the largest region in the cancer cell analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer cell analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer cell analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer cell analysis market includes revenues earned by entities by providing services such as consulting and research support services, data analysis and bioinformatics services, drug screening and efficacy testing, histopathology and digital pathology services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cancer cell analysis market also includes sales of digital pathology scanners, microfluidic devices, liquid biopsy kits, and immunohistochemistry (IHC) kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Cell Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer cell analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer cell analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer cell analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Reagents And Consumables; Instruments; Accessories; Software; Service
  • 2) By Type Of Analysis: Genomic Analysis; Proteomic Analysis; Metabolomic Analysis; Transcriptomic Analysis; Histopathological Analysis
  • 3) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Mass Spectrometry; Flow Cytometry; Immunohistochemistry (IHC)
  • 4) By Application: Biomarker Discovery; Drug Development And Discovery; Precision Medicine; Clinical Diagnosis; Research And Development
  • 5) By End-Use: Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Testing Laboratories; Academic And Research Institutes; Other End-Uses
  • Subsegments:
  • 1) By Reagents And Consumables: Cell Culture Media; Antibodies; Stains And Dyes; Enzyme Kits; Buffers And Solutions
  • 2) By Instruments: Flow Cytometers; Microscopes; Cell Analyzers; Automated Cell Counters; Imaging Systems
  • 3) By Accessories: Pipettes And Tips; Culture Plates And Flasks; Microplates; Filtration Units; Sample Tubes
  • 4) By Software: Data Analysis Software; Image Analysis Software; Laboratory Information Management Systems; Visualization Tools; Quantification Software
  • 5) By Service: Technical Support Services; Installation And Maintenance Services; Calibration Services; Training And Education Services; Consultation Services
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Merck KGaA; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Olympus Corporation; Illumina Inc.; Sartorius AG; PerkinElmer Inc.; Sysmex Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Miltenyi Biotec B.V. & Co. KG; Abcam plc; Promega Corporation; Creative Bioarray Inc.; NanoCellect Biomedical Inc.; Cell Biolabs Inc.; Meiji Techno Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Cell Analysis Market Characteristics

3. Cancer Cell Analysis Market Trends And Strategies

4. Cancer Cell Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Cell Analysis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Cell Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Cell Analysis Market Growth Rate Analysis
  • 5.4. Global Cancer Cell Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Cell Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Cell Analysis Total Addressable Market (TAM)

6. Cancer Cell Analysis Market Segmentation

  • 6.1. Global Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Accessories
  • Software
  • Service
  • 6.2. Global Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomic Analysis
  • Proteomic Analysis
  • Metabolomic Analysis
  • Transcriptomic Analysis
  • Histopathological Analysis
  • 6.3. Global Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Mass Spectrometry
  • Flow Cytometry
  • Immunohistochemistry (IHC)
  • 6.4. Global Cancer Cell Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biomarker Discovery
  • Drug Development And Discovery
  • Precision Medicine
  • Clinical Diagnosis
  • Research And Development
  • 6.5. Global Cancer Cell Analysis Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinical Testing Laboratories
  • Academic And Research Institutes
  • Other End-Uses
  • 6.6. Global Cancer Cell Analysis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Media
  • Antibodies
  • Stains And Dyes
  • Enzyme Kits
  • Buffers And Solutions
  • 6.7. Global Cancer Cell Analysis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flow Cytometers
  • Microscopes
  • Cell Analyzers
  • Automated Cell Counters
  • Imaging Systems
  • 6.8. Global Cancer Cell Analysis Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pipettes And Tips
  • Culture Plates And Flasks
  • Microplates
  • Filtration Units
  • Sample Tubes
  • 6.9. Global Cancer Cell Analysis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Image Analysis Software
  • Laboratory Information Management Systems
  • Visualization Tools
  • Quantification Software
  • 6.10. Global Cancer Cell Analysis Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technical Support Services
  • Installation And Maintenance Services
  • Calibration Services
  • Training And Education Services
  • Consultation Services

7. Cancer Cell Analysis Market Regional And Country Analysis

  • 7.1. Global Cancer Cell Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Cell Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Cell Analysis Market

  • 8.1. Asia-Pacific Cancer Cell Analysis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Cell Analysis Market

  • 9.1. China Cancer Cell Analysis Market Overview
  • 9.2. China Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Cell Analysis Market

  • 10.1. India Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Cell Analysis Market

  • 11.1. Japan Cancer Cell Analysis Market Overview
  • 11.2. Japan Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Cell Analysis Market

  • 12.1. Australia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Cell Analysis Market

  • 13.1. Indonesia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Cell Analysis Market

  • 14.1. South Korea Cancer Cell Analysis Market Overview
  • 14.2. South Korea Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Cell Analysis Market

  • 15.1. Western Europe Cancer Cell Analysis Market Overview
  • 15.2. Western Europe Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Cell Analysis Market

  • 16.1. UK Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Cell Analysis Market

  • 17.1. Germany Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Cell Analysis Market

  • 18.1. France Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Cell Analysis Market

  • 19.1. Italy Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Cell Analysis Market

  • 20.1. Spain Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Cell Analysis Market

  • 21.1. Eastern Europe Cancer Cell Analysis Market Overview
  • 21.2. Eastern Europe Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Cell Analysis Market

  • 22.1. Russia Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Cell Analysis Market

  • 23.1. North America Cancer Cell Analysis Market Overview
  • 23.2. North America Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Cell Analysis Market

  • 24.1. USA Cancer Cell Analysis Market Overview
  • 24.2. USA Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Cell Analysis Market

  • 25.1. Canada Cancer Cell Analysis Market Overview
  • 25.2. Canada Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Cell Analysis Market

  • 26.1. South America Cancer Cell Analysis Market Overview
  • 26.2. South America Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Cell Analysis Market

  • 27.1. Brazil Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Cell Analysis Market

  • 28.1. Middle East Cancer Cell Analysis Market Overview
  • 28.2. Middle East Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Cell Analysis Market

  • 29.1. Africa Cancer Cell Analysis Market Overview
  • 29.2. Africa Cancer Cell Analysis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Cell Analysis Market, Segmentation By Type Of Analysis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Cell Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Cell Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Cell Analysis Market Competitive Landscape
  • 30.2. Cancer Cell Analysis Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Cell Analysis Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. GE Healthcare Technologies Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Agilent Technologies Inc.
  • 31.5. Olympus Corporation
  • 31.6. Illumina Inc.
  • 31.7. Sartorius AG
  • 31.8. PerkinElmer Inc.
  • 31.9. Sysmex Corporation
  • 31.10. Bruker Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. QIAGEN N.V.
  • 31.13. Tecan Group Ltd.
  • 31.14. Miltenyi Biotec B.V. & Co. KG
  • 31.15. Abcam plc

32. Global Cancer Cell Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Cell Analysis Market

34. Recent Developments In The Cancer Cell Analysis Market

35. Cancer Cell Analysis Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Cell Analysis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Cell Analysis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Cell Analysis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer